Darin M. Lippoldt

Darin M. Lippoldt is currently the Chief Legal Officer at Neurocrine Biosciences. Darin has held this position since October 2014. Prior to that, they were the Executive Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary at Volcano Corporation from July 2010 to October 2014. From November 2003 to July 2010, Darin M. Lippoldt was the Associate General Counsel at Amylin Pharmaceuticals. Darin began their career as a Senior Associate at Fulbright & Jaworski from December 1996 to November 2003. Darin M. Lippoldt then became an Associate at Matthews & Branscomb from February 1994 to December 1996.

Darin M. Lippoldt has a Master of Arts in International Relations from St. Mary's University, a Juris Doctor from St. Mary's University School of Law, and a Bachelor of Business Administration in Finance from St. Mary's University.

Darin M. Lippoldt reports to Kevin C. Gorman, CEO. Some of their coworkers include Dimitri E. Grigoriadis - Chief Research Officer, Kyle Gano - Chief Business Development Officer, and Matthew C. Abernethy - Chief Financial Officer.